NEW Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the diabetes medicine Vildagliptin and Vildagliptin /Metformin in Africa

We at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines available and affordable to as many people as possible around the world. That´s why we are happy to share that we have successfully prepared the launch of the generic version of Vildagliptin and the combination product Vildagliptin/Metformin in Africa. Vildagliptin and Vildagliptin/Metformin are diabetes medicines that are used to control the blood glucose (sugar) in adults with type 2 diabetes. The tablets are marketed in South Africa (Vildagliptin 50 mg) and Namibia (Vildagliptin/Metformin 50/1000 mg) by our marketing partner, a well-known South African based pharmaceutical company. The products have been developed in TIEFENBACHER GROUP´s own laboratories in Hyderabad, India, and will be marketed in Europe and further international countries as soon as the patents of the originator products have expired.

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).  

For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or please visit us on:www.tiefenbacher-pharmaceuticals.com

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com